Home FDA approves once-monthly Abilify for schizophrenia
 

Keywords :   


FDA approves once-monthly Abilify for schizophrenia

2013-03-01 04:10:30| Biotech - Topix.net

U.S. regulators on Thursday approved a once-monthly injectable form of Abilify, the blockbuster treatment for schizophrenia, which will be sold by Japanese drugmaker Otsuka and Danish drug group Lundbeck .

Tags: fda approves schizophrenia fda approves

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.11JELEEBOX
26.11
26.11222CB
26.11BOSS ( ) BB-1X Bass Driver
26.1112010 re0827-141
26.11
26.11 2021 EDITION
26.11DVD
More »